0 Comentários
0 Compartilhamentos
422 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
- Faça Login para curtir, compartilhar e comentar!
- Neurodegenerative Disease Market Size, Share, Trends, Opportunities, Key Drivers and Growth ProspectusThe global Neurodegenerative Disease market size reached USD 52.03 billion in 2023. Looking forward, Analytica Global expects the market to reach USD 102.6 billion by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032. Analytica Global Research newly added a research report on the Global Neurodegenerative Disease Market, which represents a study for the period from 2024 to...0 Comentários 0 Compartilhamentos 454 Visualizações 0 Anterior
- Patient-Centric Approaches: Shaping the Future of Neurodegenerative Disease MarketThe report presents detailed information regarding the prominent players and potential competitors in the Neurodegenerative Disease Market. It includes comprehensive insights into their worldwide presence, economic performance, strategies, upcoming product releases, research and development initiatives. Additionally, the report analyses revenue share and contact details for each player.This...0 Comentários 0 Compartilhamentos 365 Visualizações 0 Anterior
- Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Is Estimated To Witness High Growth Owing To Rising Prevalence of ALS & Increasing R&D InvestmentsThe Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market is estimated to be valued at US$662.3 million in 2023 and is expected to exhibit a CAGR of 4.6% over the forecast period from 2023 to 2030, according to a new report published by Coherent Market Insights.Market Overview:The Amyotrophic Lateral Sclerosis (ALS) Treatment Market deals with the development and commercialization of...0 Comentários 0 Compartilhamentos 1810 Visualizações 0 Anterior
- Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Is Estimated To Witness High Growth Owing To Rising Prevalence of ALS & Increasing R&D InvestmentsThe Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market is estimated to be valued at US$662.3 million in 2023 and is expected to exhibit a CAGR of 4.6% over the forecast period from 2023 to 2030, according to a new report published by Coherent Market Insights.Market Overview:The Amyotrophic Lateral Sclerosis (ALS) Treatment Market deals with the development and commercialization of...0 Comentários 0 Compartilhamentos 1718 Visualizações 0 Anterior
- Multiple Sclerosis Therapeutics: Recent Advances in Therapeutics for Multiple SclerosisMultiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system that damages myelin, the protective sheath surrounding nerve fibers of the brain, spinal cord, and optic nerves. This damage disrupts communication between the brain and other parts of the body. MS destroys myelin and the myelin-forming cells (oligodendrocytes) and in some cases also attacks the axons...0 Comentários 0 Compartilhamentos 293 Visualizações 0 Anterior
- The Global Memantine Market Growth Is driven by rising prevalence of Alzheimer's diseaseThe memantine market overview involves neuroprotective properties of memantine for treatment of moderate to severe forms of Alzheimer's disease. Memantine is an NMDA receptor antagonist approved as an add-on therapy to cholinesterase inhibitors for patients with moderate to severe Alzheimer's disease. It regulates glutamate activity to inhibit neurotoxicity and protect neurons from...0 Comentários 0 Compartilhamentos 548 Visualizações 0 Anterior